Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kronos Bio Inc.

    NASDAQ: KRON · Real-Time Price · USD
    0.88
    0.01 (1.49%)
    At close: Jun 20, 2025, 9:43 AM
    1.49%
    Bid 0.87
    Market Cap 53.65M
    Revenue (ttm) 9.19M
    Net Income (ttm) -64.48M
    EPS (ttm) -1.07
    PE Ratio (ttm) -0.82
    Forward PE -0.64
    Analyst Hold
    Ask 0.88
    Volume 53,687
    Avg. Volume (20D) 862,854
    Open 0.88
    Previous Close 0.87
    Day's Range 0.87 - 0.88
    52-Week Range 0.65 - 1.60
    Beta 1.64

    About KRON

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol KRON
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for KRON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 weeks ago
    +28.91%
    Kronos Bio shares are trading higher after the com... Unlock content with Pro Subscription
    1 month ago
    -19.98%
    Kronos Bio shares are trading lower after the company announced it will be acquired by Concentra Biosciences for $0.57 in cash per share plus a contingent value right.
    news image

    3 days ago · marketwatch.com

    Kronos Bio Completes Sale to Concentra Biosciences

    Kronos Bio completed its sale to Concentra Biosciences for 57 cents a share in cash plus contingent value rights related to cost savings and potential proceeds from disposition of drug candidates.

    news image

    1 month ago · businesswire.com

    KRONOS BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kronos Bio, Inc. - KRON

    NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ...

    news image

    1 month ago · businesswire.com

    Shareholder Alert: The Ademi Firm Investigates Whether Kronos Bio, Inc. is Obtaining a Fair Price for Its Public Shareholders

    MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Kronos (Nasdaq: KRON) for possible breaches of fiduciary duty and other violations of law in its transaction with Concentra. Click here to l...

    news image

    1 month ago · businesswire.com

    KRON Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Kronos Bio, Inc. Is Fair to Shareholders

    NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Kronos Bio, Inc. (NASDAQ: KRON) to Concentra Biosciences, LLC for $0.57 in cash per share...

    Add to Watchlist